These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19020018)

  • 1. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
    Rao MV; Mohan PS; Peterhoff CM; Yang DS; Schmidt SD; Stavrides PH; Campbell J; Chen Y; Jiang Y; Paskevich PA; Cataldo AM; Haroutunian V; Nixon RA
    J Neurosci; 2008 Nov; 28(47):12241-54. PubMed ID: 19020018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.
    Rao MV; Campbell J; Palaniappan A; Kumar A; Nixon RA
    J Neurochem; 2016 Apr; 137(2):253-65. PubMed ID: 26756888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors.
    Higuchi M; Tomioka M; Takano J; Shirotani K; Iwata N; Masumoto H; Maki M; Itohara S; Saido TC
    J Biol Chem; 2005 Apr; 280(15):15229-37. PubMed ID: 15699033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology.
    Higuchi M; Iwata N; Matsuba Y; Takano J; Suemoto T; Maeda J; Ji B; Ono M; Staufenbiel M; Suhara T; Saido TC
    FASEB J; 2012 Mar; 26(3):1204-17. PubMed ID: 22173972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.
    Veeranna ; Kaji T; Boland B; Odrljin T; Mohan P; Basavarajappa BS; Peterhoff C; Cataldo A; Rudnicki A; Amin N; Li BS; Pant HC; Hungund BL; Arancio O; Nixon RA
    Am J Pathol; 2004 Sep; 165(3):795-805. PubMed ID: 15331404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
    Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
    Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse.
    Schoch KM; von Reyn CR; Bian J; Telling GC; Meaney DF; Saatman KE
    J Neurochem; 2013 Jun; 125(6):909-20. PubMed ID: 23305291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
    Seo J; Jo SA; Hwang S; Byun CJ; Lee HJ; Cho DH; Kim D; Koh YH; Jo I
    FEBS J; 2013 Dec; 280(24):6691-701. PubMed ID: 24200051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpain cleavage and inactivation of the sodium calcium exchanger-3 occur downstream of Aβ in Alzheimer's disease.
    Atherton J; Kurbatskaya K; Bondulich M; Croft CL; Garwood CJ; Chhabra R; Wray S; Jeromin A; Hanger DP; Noble W
    Aging Cell; 2014 Feb; 13(1):49-59. PubMed ID: 23919677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.
    Schoch KM; Evans HN; Brelsfoard JM; Madathil SK; Takano J; Saido TC; Saatman KE
    Exp Neurol; 2012 Aug; 236(2):371-82. PubMed ID: 22572592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.
    Rao MV; McBrayer MK; Campbell J; Kumar A; Hashim A; Sershen H; Stavrides PH; Ohno M; Hutton M; Nixon RA
    J Neurosci; 2014 Jul; 34(28):9222-34. PubMed ID: 25009256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of axon degeneration after injury and in development by the endogenous calpain inhibitor calpastatin.
    Yang J; Weimer RM; Kallop D; Olsen O; Wu Z; Renier N; Uryu K; Tessier-Lavigne M
    Neuron; 2013 Dec; 80(5):1175-89. PubMed ID: 24210906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo role of caspases in excitotoxic neuronal death: generation and analysis of transgenic mice expressing baculoviral caspase inhibitor, p35, in postnatal neurons.
    Tomioka M; Shirotani K; Iwata N; Lee HJ; Yang F; Cole GM; Seyama Y; Saido TC
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):18-32. PubMed ID: 12480175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
    Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
    J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions.
    Liu MC; Kobeissy F; Zheng W; Zhang Z; Hayes RL; Wang KK
    ASN Neuro; 2011 Feb; 3(1):e00051. PubMed ID: 21359008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling.
    Kudo-Sakamoto Y; Akazawa H; Ito K; Takano J; Yano M; Yabumoto C; Naito AT; Oka T; Lee JK; Sakata Y; Suzuki J; Saido TC; Komuro I
    J Biol Chem; 2014 Jul; 289(28):19408-19. PubMed ID: 24891510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calpastatin Mediates Development of Alzheimer's Disease in Diabetes.
    Zhu L; Gong L; Yang T; Xiao X
    J Alzheimers Dis; 2019; 68(3):1051-1059. PubMed ID: 30909245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpastatin overexpression attenuates amyloid-beta-peptide toxicity in differentiated PC12 cells.
    Vaisid T; Barnoy S; Kosower NS
    Neuroscience; 2008 Oct; 156(4):921-31. PubMed ID: 18786620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calpain activation and alpha-spectrin cleavage in rat brain by ethanol.
    Rajgopal Y; Vemuri MC
    Neurosci Lett; 2002 Mar; 321(3):187-91. PubMed ID: 11880203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.